The role of the National Cancer Institute in drug development

Clin Adv Hematol Oncol. 2005 Apr;3(4):257-8.
No abstract available

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic*
  • Drug Design
  • Drug Industry
  • Drug Screening Assays, Antitumor
  • Drugs, Investigational / pharmacology
  • Drugs, Investigational / therapeutic use
  • Humans
  • Intellectual Property
  • Interprofessional Relations
  • National Institutes of Health (U.S.)* / organization & administration
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy
  • Public Opinion
  • Role
  • United States

Substances

  • Antineoplastic Agents
  • Drugs, Investigational